Kalos Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Kalos Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $1.09 Million - $1.38 Million	-2,277 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $524,594 - $633,856	-963 Reduced 29.72%	2,277 $1.27 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $367,030 - $479,076	-744 Reduced 18.67%	3,240 $1.94 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $335,843 - $493,935	-999 Reduced 20.05%	3,984 $2.29 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $12,609 - $17,319	46 Added 0.93%	4,983 $1.87 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $1.35 Million - $1.57 Million	4,937 New	4,937 $1.37 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.